Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prurigo Nodularis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03816891
What this trial is testing

Study to Assess the Efficacy, Safety, and Tolerability of Vixarelimab in Reducing Pruritus in Prurigo Nodularis

Who this might be right for
Prurigo NodularisPruritis
Genentech, Inc. 240
Not applicableActive Not RecruitingNCT05991323
What this trial is testing

Real-World Effectiveness of Dupilumab in Patients With Prurigo Nodularis: An Observational Study

Who this might be right for
Prurigo Nodularis
Sanofi 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07620561
What this trial is testing

Efficacy and Speed of Response of Lebrikizumab in High-Burden Prurigo Nodularis Patients

Who this might be right for
Prurigo Nodularis (PN)
University of Maryland, Baltimore 15
Early research (Phase 1)Study completedNCT06342713
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single- and Multiple-Ascending Doses and Food Effect of BGB-45035 in Healthy Participants and in Adults With Autoimmune Dermatological Diseases

Who this might be right for
Healthy ParticipantsHealthy SubjectsHealthy Volunteers+4 more
BeiGene 203
Large-scale testing (Phase 3)Study completedNCT04183335
What this trial is testing

Study of Dupilumab for the Treatment of Patients With Prurigo Nodularis, Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable (LIBERTY-PN PRIME)

Who this might be right for
Neurodermatitis
Sanofi 151
Not applicableLooking for participantsNCT05316805
What this trial is testing

China Type II Inflammatory Skin Disease Clinical Research and Standardized Diagnosis and Treatment Project

Who this might be right for
Atopic Dermatitis EczemaPrurigo Nodularis
Peking University First Hospital 100,000
Large-scale testing (Phase 3)Looking for participantsNCT06779136
What this trial is testing

Phase III Clinical Study of MG-K10 Humanized Mab Injection in Subjects With Prurigo Nodularis

Who this might be right for
Prurigo Nodularis
Shanghai Mabgeek Biotech.Co.Ltd 160
Large-scale testing (Phase 3)Ended earlyNCT06527404
What this trial is testing

A Phase 3, Placebo-controlled, Double-blind Study Assessing Rocatinlimab in Prurigo Nodularis

Who this might be right for
Prurigo Nodularis
Amgen 469
Testing effectiveness (Phase 2)Study completedNCT05061693
What this trial is testing

Evaluate the Efficacy and Safety of INCB054707 in Participants With Prurigo Nodularis

Who this might be right for
Prurigo Nodularis
Incyte Corporation 146
Testing effectiveness (Phase 2)Looking for participantsNCT07236099
What this trial is testing

Study of the Efficacy and Safety of ICP-332 in Participants With Prurigo Nodularis

Who this might be right for
Prurigo Nodularis (PN)
Beijing InnoCare Pharma Tech Co., Ltd. 135
Testing effectiveness (Phase 2)Study completedNCT00507832
What this trial is testing

Evaluation of the Antipruritic Effect of Elidel (Pimecrolimus) in Non-atopic Pruritic Disease

Who this might be right for
Prurigo Nodularis
University Hospital Muenster 30
Testing effectiveness (Phase 2)UnknownNCT03576287
What this trial is testing

Apremilast as Anti-pruritic Treatment in Patients With Prurigo Nodularis

Who this might be right for
Prurigo Nodularis
Tanja Todberg, MD 15
Large-scale testing (Phase 3)UnknownNCT06524323
What this trial is testing

A Randomized, Double-blinded, Self-controlled Clinical Study of Intralesional Injection of 5-fluorouracil Plus Triamcinolone for the Treatment of Refractory Nodular Prurigo

Who this might be right for
Nodular Prurigo
Second Affiliated Hospital, Zhejiang University, School of Medicine 60
Large-scale testing (Phase 3)Active Not RecruitingNCT06516952
What this trial is testing

Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN1)

Who this might be right for
Prurigo Nodularis
Incyte Corporation 349
Large-scale testing (Phase 3)Looking for participantsNCT06293053
What this trial is testing

Investigate the Pharmacokinetics and Safety of Dupilumab in Participants ≥6 Months to <18 Years of Age With Prurigo Nodularis

Who this might be right for
Prurigo Nodularis
Sanofi 18
Large-scale testing (Phase 3)Looking for participantsNCT06554509
What this trial is testing

Clinical Study of the Efficacy and Safety of SHR-1819 Injection in Adult Patients With Prurigo Nodularis

Who this might be right for
Prurigo Nodularis
Guangdong Hengrui Pharmaceutical Co., Ltd 423
Early research (Phase 1)Study completedNCT05405985
What this trial is testing

Study to Access the Relative Bioavailability of Subcutaneous Dose of Nemolizumab When Administered Via Auto-Injector Versus Dual-Chamber Syringe

Who this might be right for
Healthy Volunteers
Galderma R&D 192
Testing effectiveness (Phase 2)Study completedNCT05038982
What this trial is testing

Efficacy of Abrocitinib for Reducing Pruritus in Adults With Prurigo Nodularis and Chronic Pruritus of Unknown Origin

Who this might be right for
Prurigo NodularisPruritusChronic Pruritus+2 more
Johns Hopkins University 20
Early research (Phase 1)Study completedNCT04944862
What this trial is testing

CDX-0159 in Patients With Prurigo Nodularis

Who this might be right for
Prurigo Nodularis
Celldex Therapeutics 24
Large-scale testing (Phase 3)Study completedNCT03497975
What this trial is testing

PRISM Study-Pruritus Relief Through Itch Scratch Modulation

Who this might be right for
Prurigo Nodularis
Trevi Therapeutics 353
Next Page